Psychiatry and Neurology, Neurology · Marrero, LA
NPI
1982640074
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1111 Medical Center Blvd, Ste S-750
Marrero, LA, 70072
Phone (504) 340-6976
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
1,963 services
Medicare patients, 2024
340
Average age 72
Drug cost, 2024
$584K
2,670 prescriptions
Company payments, 2025
$1,327
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael A Puente was code 99232 (hospital e&m - subsequent), 741 times for 148 patients. In total Michael A Puente billed 1,963 services in 27 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 741 | 148 | $59.87 | $44K |
| G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 192 | 16 | $24.46 | $4,697 |
| 99214 Office E&M - Established | Office | 188 | 130 | $90.07 | $17K |
| 99223 Hospital E&M - Initial | Facility | 104 | 95 | $129.77 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 95 | 75 | $89.95 | $8,545 |
| 99239 Hospital Discharge Management | Facility | 41 | 38 | $85.09 | $3,489 |
| 95886 Electrical Nerve Conductivity | Office | 34 | 20 | $71.77 | $2,440 |
| 99204 Office E&M - New | Office | 32 | 32 | $115.46 | $3,695 |
| 99213 Office E&M - Established | Office | 23 | 18 | $58.56 | $1,347 |
| 95938 Electrical Nerve Conductivity | Facility | 17 | 16 | $32.67 | $555 |
| 95910 Electrical Nerve Conductivity | Office | 17 | 17 | $131.77 | $2,240 |
| 95819 Neurologic | Facility | 15 | 13 | $42.87 | $643 |
| 95819 Neurologic | Office | 14 | 14 | $313.44 | $4,388 |
By year: 2022 $131K for 3,826 services; 2023 $122K for 3,654 services; 2024 $113K for 1,963 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael A Puente prescribed most often to Medicare patients was Donepezil Hcl, with 281 prescriptions and refills. In total Michael A Puente wrote 2,670 Medicare prescriptions that cost $584K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 281 | 757 | 90 | $2,327 |
| Memantine Hcl Generic | 240 | 615 | 69 | $8,799 |
| Levetiracetam Generic | 174 | 437 | 52 | $5,505 |
| Gabapentin Generic | 147 | 359 | 49 | $3,648 |
| Topiramate Generic | 94 | 280 | 25 | $1,127 |
| Primidone Generic | 93 | 258 | 23 | $3,020 |
| Sertraline Hcl Generic | 60 | 164 | 17 | $349 |
| Clonazepam Generic | 60 | 78 | Under 11 | $507 |
| Escitalopram Oxalate Generic | 60 | 154 | 21 | $433 |
| Lacosamide Generic | 55 | 83 | 12 | $2,361 |
| Tizanidine Hcl Generic | 54 | 130 | 15 | $1,226 |
| Pregabalin Generic | 53 | 106 | 14 | $1,387 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 52 | 140 | 18 | $1,150 |
| Phenobarbital Generic | 52 | 95 | Under 11 | $1,945 |
| Pyridostigmine Bromide Generic | 42 | 84 | 11 | $3,785 |
Brand drugs: 171 claims; generic drugs: 2,447 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael A Puente $1,327 ($1,327 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $496.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 38 | $496 |
| Eisai Inc. 4523.T | 13 | $139 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $100 |
| Argenx US, Inc. ARGX | 4 | $91.32 |
| Neurelis, Inc. | 4 | $83.03 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $71.58 |
| ACADIA Pharmaceuticals Inc ACAD | 3 | $58.83 |
| Merz Pharmaceuticals, LLC | 2 | $52.25 |
| Biogen, Inc. BIIB | 2 | $38.73 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $27.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.